Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Kirske currently holds 167,750 shares of CTI BIOPHARMA CORP (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Kirske has been a net seller of CTIC stock. They have purchased $0 and sold $1.8M worth of shares.
David Kirske's most recent insider trade was on Jun 30, 2026, when they sold 8,543 shares at $4.26 per share.
David Kirske serves as Executive at CTI BIOPHARMA CORP (CTIC). They have executed 40 insider transactions totaling $1.8M over their tenure at the company.
David Kirske holds the position of Executive at CTI BIOPHARMA CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
David Kirske has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Kirske was on Sep 30, 2022, when they sold $846.0K worth of CTIC shares. This transaction involved 139,841 shares at $6.05 per share.
David Kirske currently owns 167,750 shares of CTI BIOPHARMA CORP (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Kirske's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Kirske has 40 Form 4 filings on record as an insider at CTI BIOPHARMA CORP.
Set alerts for David Kirske and 40,000+ other insiders.